Status:
UNKNOWN
Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer
Lead Sponsor:
KU Leuven
Conditions:
Chronic Obstructive Pulmonary Disease
Lung Cancer
Eligibility:
All Genders
25+ years
Brief Summary
A biobank of Serum, plasma, DNA samples together with clinical information including specific questionnaires, complete pulmonary function and chest CT-scan, is prospectively collected in patients seen...
Detailed Description
All patients with a smoking history of at least 15 pack years, an minimal age of 50 years and an recent available CT scan are enrolled. All subjects with a diagnosis of lung cancer are also collected...
Eligibility Criteria
Inclusion
- Inclusion Criteria for smokers:
- A smoking history of at least 15 pack years and age of 50 years or older
- Complete pulmonary function on day of visit
- Chest CT-scan within one year of enrollment
- 4 weeks from exacerbation
- Exclusion Criteria for smokers:
- Less than 15 pack years
- Younger than 50 year
- Other pulmonary diseases interfering with CT or pulmonary function
- Asthma
- Inclusion Criteria for lung cancer patients:
- new diagnosis of proven lung cancer
- chest CT scan within 2 months of enrollment
- Complete pulmonary function
- Exclusion Criteria for lung cancer patients
- not able to perform pulmonary function
- Absence of histological diagnosis of lung cancer
Exclusion
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00858520
Start Date
October 1 2007
End Date
December 1 2019
Last Update
September 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Katholieke Universiteit Leuven
Leuven, Flanders, Belgium, 3000